TopleyN., WilliamsJ.D.The role of the peritoneal membrane in the control of inflammation in the peritoneal cavity.Kidney Int1994; 46: S71–S78.
2.
ZemelD., ImholzA.L.T., de WartD.R.The appearance of tumour necrosis factor-α and soluble TNF receptors I and II in peritoneal effluent during stable and infectious CAPD.Kidney Int1994; 46: 1422–30.
3.
BraunerA., HylanderB., WretlindB.Interleukin-6 and interleukin-8 in dialysate and serum from patients on continuous ambulatory peritoneal dialysis.Am J Kidney Dis1993; 22: 430–5.
4.
GoldmanM., VandenabeeleP., MoulartJ.Intraperitoneal secretion of interleukin-6 during continuous ambulatory peritoneal dialysis.Nephron1990; 56: 277–80.
5.
ZemelD., KredietR.T., KoomenG.C.M.Interleukin8 during peritonitis in patients treated with CAPD; an in vivo model of acute inflammation.Nephrol Dial Transplant1994; 9: 169–74.
TopleyN., JörresA., LuttmannW.Humanperitoneal mesothelial cells synthesize IL-6: induction by IL-lβ and TNFα.Kidney Int1993; 43: 226–33.
8.
BetjesM.G.H., TukC.W., StruijkD.G.Interleukin8 production by human peritoneal mesothelial cells in response to tumor necrosis factor α, interleukin-l, and medium conditioned by macrophages co-cultured with Staphylococcus epidermidis.J Infect Dis1993; 168: 1202–10.
